NIHR Medicines for Children Research Network: improving children’s health through clinical research

2013 ◽  
Vol 6 (5) ◽  
pp. 581-587 ◽  
Author(s):  
Andrew C Rose ◽  
William van’t Hoff ◽  
Michael W Beresford ◽  
Susan P Tansey
PEDIATRICS ◽  
1998 ◽  
Vol 102 (6) ◽  
pp. 1350-1357 ◽  
Author(s):  
R. C. Wasserman ◽  
E. J. Slora ◽  
A. B. Bocian ◽  
G. V. Fleming ◽  
A. E. Baker ◽  
...  

Clinical Risk ◽  
2011 ◽  
Vol 17 (6) ◽  
pp. 214-216 ◽  
Author(s):  
Mark Anderson

The risk to children's health from medicines both prescribed and unprescribed is not insignificant and is probably greater than for adults. It arises from a long standing, and only recently rectified, lack of investment of research into the area of medicines for children, combined with the greater susceptibility of this age group to the effects of human error. This article explores some of the issues that contribute to this risk.


Sign in / Sign up

Export Citation Format

Share Document